UK Outlines Issues With Illumina's $1B DNA Sequencing Buy

DNA-sequencing company Illumina Inc.'s proposed $1.2 billion takeover of Pacific Biosciences of California Inc. has run into resistance from the U.K.'s antitrust watchdog amid concerns that the merger would threaten the...

Already a subscriber? Click here to view full article